Moreover, animal models of AD showed that rTMS effectively reduces Aβ levels and the activation of microglia and decreases levels of pro-inflammatory cytokines including IL-6 and TNF-α as well as regulated PI3K/Akt/NF-κB signaling pathway [32]. This evidence concerns the gene AKT1 and Alzheimer disease.